- Home
- FFWM vs ARCT Comparison
FFWM vs ARCT Comparison
Compare FFWM & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFWM
- ARCT
- Stock Information
- Founded
- FFWM 1990
- ARCT 2013
- Country
- FFWM United States
- ARCT United States
- Employees
- FFWM N/A
- ARCT N/A
- Industry
- FFWM Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- FFWM Finance
- ARCT Health Care
- Exchange
- FFWM Nasdaq
- ARCT Nasdaq
- Market Cap
- FFWM 409.3M
- ARCT 487.0M
- IPO Year
- FFWM 2014
- ARCT N/A
- Fundamental
- Price
- FFWM $5.21
- ARCT $16.36
- Analyst Decision
- FFWM Buy
- ARCT Strong Buy
- Analyst Count
- FFWM 4
- ARCT 8
- Target Price
- FFWM $6.75
- ARCT $61.00
- AVG Volume (30 Days)
- FFWM 516.6K
- ARCT 405.9K
- Earning Date
- FFWM 01-30-2025
- ARCT 03-06-2025
- Dividend Yield
- FFWM 0.20%
- ARCT N/A
- EPS Growth
- FFWM N/A
- ARCT N/A
- EPS
- FFWM N/A
- ARCT N/A
- Revenue
- FFWM $96,072,000.00
- ARCT $160,399,000.00
- Revenue This Year
- FFWM N/A
- ARCT $7.33
- Revenue Next Year
- FFWM $12.65
- ARCT $4.71
- P/E Ratio
- FFWM N/A
- ARCT N/A
- Revenue Growth
- FFWM N/A
- ARCT N/A
- 52 Week Low
- FFWM $4.66
- ARCT $14.30
- 52 Week High
- FFWM $8.72
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- FFWM 33.41
- ARCT 45.85
- Support Level
- FFWM $4.66
- ARCT $15.34
- Resistance Level
- FFWM $6.46
- ARCT $17.95
- Average True Range (ATR)
- FFWM 0.29
- ARCT 1.17
- MACD
- FFWM -0.08
- ARCT -0.08
- Stochastic Oscillator
- FFWM 30.39
- ARCT 39.08
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.